Uterine Cancer Surge Predicted; Black Women Face Triple Mortality Risk by 2050

July 1, 2025
Uterine Cancer Surge Predicted; Black Women Face Triple Mortality Risk by 2050
  • Uterine cancer cases in the U.S. are expected to rise significantly by 2050, with a notable threefold increase in mortality rates among Black women, according to a recent study by the American Association for Cancer Research.

  • In 2024, nearly 70,000 cases of uterine cancer were reported, making it the most common gynecologic cancer in the country.

  • Key factors driving the projected increase in uterine cancer cases include an aging population, rising obesity rates, and a decline in hysterectomies for conditions like fibroids and endometriosis.

  • Emerging treatments such as immunotherapy and biomarker-based therapies show promise for improving outcomes, while addressing obesity may also help reduce the incidence of new cases.

  • Disparities in uterine cancer outcomes are exacerbated by delays in diagnosis, barriers to accessing care, and sub-optimal treatment options, particularly for Black women.

  • Research has linked the use of chemical hair relaxers, which approximately 95% of Black women under 45 have used, to an increased risk of uterine cancer due to harmful toxins.

  • The decrease in hysterectomies has resulted in more women retaining their uterus, thereby increasing the risk of developing uterine cancer.

  • The findings of this study were published on July 1 in the journal Cancer Epidemiology, Biomarkers & Prevention, and were supported by a National Institutes of Health grant.

  • The research utilized a natural history model to forecast trends based on various factors including age, cancer type, race, obesity rates, and hysterectomy history.

  • While the overall five-year survival rate for uterine cancer is 81%, it dramatically decreases to between 20-50% for more aggressive forms of the disease, which disproportionately affect Black women.

  • The study emphasizes the need for new screening methods, as current diagnostic techniques are limited to symptomatic women, leaving asymptomatic cases undetected.

  • Implementing effective screening tests starting at age 55 could significantly reduce uterine cancer cases, highlighting the urgent need for improved screening and prevention strategies.

Summary based on 4 sources


Get a daily email with more Science stories

More Stories